Attention:
|
Abby Adams
|
Dorrie Yale
|
Re:
|
Rexahn Pharmaceuticals, Inc.
Registration Statement on Form S-4
File No. 333-239702
Acceleration Request
|
|
|
||
Requested Date:
|
October 2, 2020
|
|
Requested Time:
|
9:00 A.M. Eastern Time
|
|
Sincerely,
|
|
|
|
REXAHN PHARMACEUTICALS, INC.
|
|
|
|
|
|
/s/ Douglas J. Swirsky
|
|
Douglas J. Swirsky
|
|
President and Chief Executive Officer
|